You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-3. Distribution by primary drug used of new clients entering treatment, 1993 to 2005 [see all tables in this series...]

Part (iv) Percent of new clients using stimulants (amphetamines and MDMA)

Country		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005
Belgium		1.4	4.2	6.1	5.5	6.4	3.4
Bulgaria			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.5	2.0
Czech Republic				41.2	43.2	48.8	56.8	52.8	46.0	47.8	55.0	55.6	59.0	60.1
Denmark								11.0	7.0		10.3	12.7	14.2	11.2
Germany									10.2	11.4	10.0	10.2	9.4	9.4
Ireland		4.9	3.3	8.0	6.3	7.0	4.8	5.7	6.5	9.9	8.6	8.0	6.7	5.7
Greece			0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.4	0.7	0.6	0.7	0.1
Spain					1.1	1.1	2.3	2.1	2.7	3.0	3.7		1.7
France						1.8		1.6				2.1		1.2
Italy		0.2	0.3	0.3	0.4	0.6	0.9	1.1	1.0	1.0	1.0	1.0	1.0	0.9
Cyprus										6.1	6.0	6.2	5.3	1.4
Latvia											11.3	15.1	26.8	23.8
Lithuania											3.0	4.8	2.4	0.0
Luxembourg	(1)			0.0	4.0	2.0	3.0	2.0	1.0	1.0	0.0	0.0	2.5	0.4
Hungary	(2)				7.1	12.2	14.0	10.7	7.5	7.0	6.3	8.2	7.9	11.0
Malta	(3)				0.8	0.4						1.2	0.0	1.6
Netherlands			3.5	7.2	10.3	9.5	8.1	6.7	4.8	4.1	5.6	7.0	8.3	9.1
Austria	(4)		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Poland	(5)					3.8	6.0	6.7	5.8	6.0	8.1	11.9
Portugal								0.0	0.0			0.8	0.5	0.2
Romania										0.3	0.5	1.0	1.0	1.8
Slovenia						0.2		0.7			1.0	1.0	1.1
Slovakia			1.7	1.2	2.0	2.6	3.2	2.3	6.8	7.8	15.1	25.4	32.1	30.4
Finland							41.1	41.9	30.8	30.0	33.9	33.9	30.9	26.3
Sweden									28.7	32.3	34.2	32.1	28.6	25.6
United Kingdom	(6)	11.0	9.0	10.0	9.0	9.0	9.0	8.0	4.0	3.0	3.0	6.0	7.0	5.6
Turkey													7.5	7.3

Notes:

(1) Data refer to all treatments.

(2) Data refer to all treatments. For 2004 data refer to first treatments.

(3) In order to include time trends, data reported in Table 3 refer to 1 outpatient centre for which data were available for the whole time period.

(4) In the case of Austria, data only refer to clients in substitution treatment, using opioids as primary drug.

(5) Data refer to all treatments up to 2002. For 2003 data refer to first treatments. Heroin includes all opiates. For 2004 and 2005 data were not available and therefore not included in the analysis.

(6) Data refer to all treatments up to 2002 and to new treatments from 2003. Before 2003 data only refer to amphetamines.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Standard table 3 and TDI